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Edited by Giulio Superti-FurgaAbstract In previous work we showed that Abl interactor 1
(Abi-1), by linking enzyme and substrate, promotes the phos-
phorylation of Mammalian Enabled (Mena) by c-Abl. To deter-
mine whether this mechanism extends to other c-Abl substrates,
we used the yeast two-hybrid system to search for proteins that
interact with Abi-1. By screening a human leukocyte cDNA li-
brary, we identiﬁed BCAP (B-cell adaptor for phosphoinositide
3-kinase) as another Abi-1-interacting protein. Binding experi-
ments revealed that the SH3 domain of Abi-1 and the C-terminal
polyproline structure of BCAP are involved in interactions be-
tween the two. In cultured cells, Abi-1 promoted phosphorylation
of BCAP not only by c-Abl but also by v-Abl. The phosphoryla-
tion sites of BCAP by c-Abl were mapped to ﬁve tyrosine resi-
dues in the C-terminal region that are well conserved in
mammals. These results show that Abi-1 promotes Abl-mediated
BCAP phosphorylation and suggest that Abi-1 in general coordi-
nates kinase-substrate interactions.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Regulation of tyrosine kinases has been shown to be impor-
tant for diverse cellular functions such as growth and diﬀeren-
tiation. c-abl, which was identiﬁed as the protooncogene of the
Abelson leukemia virus oncogene v-abl, encodes a tyrosine ki-
nase, c-Abl [1,2]. Although the activity of c-Abl is tightly reg-
ulated, v-Abl kinase possesses an increased and unregulated
activity [3,4]. Thus, elucidation of the mechanism of regulation
of Abl kinase activity is critical to understanding not only the
c-Abl signal transduction pathway, but also the mechanism
underlying v-Abl-induced leukemia. While recent ﬁndings haveAbbreviations: BCAP, B cell adaptor for PI3-kinase; GST, glutathione-
S-transferase; PAGE, polyacrylamide gel electrophoresis; PCR, poly-
merase chain reaction
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doi:10.1016/j.febslet.2005.04.052shown that the kinase activity of c-Abl is autoregulated by its
intramolecular folding [5–7], the mechanism of how the activ-
ity of c-Abl kinase is regulated by protein–protein interactions
is poorly understood.
Our group has suggested that trans-acting adaptor mole-
cules, such as c-Crk and Abl interactor 1 (Abi-1), are impor-
tant for the regulation of c-Abl kinase [8,9]. Abi-1 was ﬁrst
identiﬁed as a c-Abl-binding protein that suppresses v-abl
transforming activity [10]. We showed that Abi-1 interacts
with Mammalian Enabled (Mena) and promotes its phosphor-
ylation by c-Abl [9]. Our results suggest that Abi-1 presents
Mena as a better substrate for c-Abl by acting as an adaptor
protein.
To examine whether this scenario for Abi-1 is applicable to
other c-Abl substrates, we sought to identify Abi-1 interacting
proteins using yeast two-hybrid screening. B cell adaptor for
phosphoinositide 3-kinase (BCAP) was found to be an Abi-
1-binding protein. As observed for Mena, Abi-1 promoted
the phosphorylation of BCAP by c-Abl in cultured cells.2. Materials and methods
2.1. Plasmids
pcDNA3 c-Abl was a gift from David Baltimore. pFLAG-CMV2
Abi-1 was constructed as described previously [9]. The coding sequence
of v-abl [1] was subcloned into the BamHI site of pcDNA3, resulting in
pcDNA3 v-Abl.
Mammalian expression plasmid pEBG (a gift from Bruce Mayer)
was used to express proteins fused with a glutathione-S-transferase
(GST) tag. Full-length human BCAP cDNA was ampliﬁed by poly-
merase chain reaction (PCR), using Marathon-Ready human bone
marrow cDNA (Clontech) as a template, the forward primer 5 0-
cgcggatccaccatggcagcctcaggggtgcc-3 0, and the reverse primer 5 0-
cgcggatcctcagcgtcctctgggtggaac-3 0. The PCR product was digested
with BamHI and inserted into the BamHI site of pEBG, resulting in
pEBG BCAP. A fragment encoding amino acids (aa) 461–805 of hu-
man BCAP was subcloned into the BamHI and NotI sites of pEBG,
resulting in pEBG BCAP (461–805). Deletion mutants of BCAP were
produced by PCR and veriﬁed by DNA sequencing.
To generate BCAP mutants in which the tyrosine residues of BCAP
were replaced with phenylalanines, oligonucleotide-directed mutagene-
sis was carried out with a Quickchange Site-Directed Mutagenesis kit
(Stratagene) according to the manufacturers instructions, using pEBG
BCAP (461–805) as the template. The mutations were veriﬁed by
sequencing. Plasmids bearing pEBG BCAP (461–805) mutations were
digested with Van91I and NotI, and the resulting fragments were in-
serted into the Van91I and NotI sites of pEBG BCAP to create pEBG
BCAP Y513, Y553, Y570, Y594, Y694, and CT5F.blished by Elsevier B.V. All rights reserved.
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The following antibodies were used: anti-Abl (8E9; Pharmingen),
anti-FLAG (M2; Sigma), anti-GST (Santa Cruz Biotechnology), and
anti-phosphotyrosine (4G10; Upstate Biotechnology, Inc.).
2.3. Two-hybrid screen and analysis
The full-length cDNA of human Abi-1 [9] was subcloned into yeast
expression vector pGBKT7. The pGBKT7 Abi-1 was transformed into
yeast strain Y190, and two-hybrid screening was then carried out
according to the manufacturers protocol using a GAL4 DNA activa-
tion domain fusion library in pGAD10 (MATCHMAKER human leu-
kocyte cDNA library; Clontech). Positive clones were isolated and
sequenced.
To examine protein–protein interactions, cDNA fragments encoding
aa 461–805 of BCAP were inserted into pGBKT7, and full-length Abi-
1 and its deletion mutants (SH3 or polyproline deletion) into
pGAD424. Yeast strain Y190 was transformed with the constructed
pGBKT7 and pGAD424 vectors. Filter assays for b-galactosidase
activity were performed according to the manufacturers protocol
(Clontech).
2.4. Transfection and GST pull-down assay
293T cells were cultured in Dulbeccos modiﬁed Eagles medium sup-
plemented with 10% fetal bovine serum and antibiotics.
Fugene6 reagent (Boehringer–Mannheim) was used for transfection
of plasmids into 293T cells. Forty-eight hours after transfection, the
cells were lysed in lysis buﬀer (1% Triton X-100, 10 mM Tris–HCl,
pH 7.6, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium
ﬂuoride, 20 mM b-glycerophosphate, 1 mM EDTA, 1 mM EGTA,
1 mM sodium vanadate, 20 lg/ml aprotinin, and 1 mM phenylmethyl-
sulfonyl ﬂuoride). The lysates were centrifuged in a microcentrifuge for
15 min at 15000 rpm to remove insoluble materials. After protein con-
tent was determined using BCA protein assay reagent (Pierce), aliquots
of lysates containing 500 lg protein were mixed with glutathione–
Sepharose 4B beads (Amersham Pharmacia Biotech) for 2 h at 4 C
with gentle rotation. The beads were washed four times with lysis buf-
fer, suspended in SDS–polyacrylamide gel electrophoresis (PAGE)
sample buﬀer, and boiled for 10 min. Proteins pulled down with the
beads were analyzed by 8% SDS–PAGE.Fig. 1. Analysis of the interaction between BCAP and Abi-1. (a)
Deletion mutants of Abi-1 are shown schematically. PP, polyproline
structure. (b) BCAP (461–805) was cloned into a GAL4 DNA-binding
domain vector, and Abi-1 or one of its deletion mutants was cloned
into a GAL4 activation domain vector. Reporter yeast cells were
transformed with the two kinds of vectors. b-Galactosidase activity
was monitored on a ﬁlter; colonies either turned blue (+) or remained
white (). (c) Schematic representation of BCAP and its deletion
mutants. AR, ankyrin repeat; PP, Polyproline structure; CC, coiled-
coil region. (d) Pull-down assay. GST (lane 1), GST–BCAP (wild type)
(lane 2), GST–BCAP (461–805) (lane 3), GST–BCAP (602–805) (lane
4), GST–BCAP (672–805) (lane 5), or GST–BCAP (1–759) (lane 6) was
co-expressed with FLAG-Abi-1 in 293T cells. Lysates of the transfec-
ted cells were incubated with glutathione beads, and bound proteins
were detected by immunoblotting with anti-FLAG and anti-GST
antibodies (GST pull-down). For estimation of the amounts of
expressed proteins, each cell lysate was separated and immunoblotted
with anti-FLAG antibody (WCL).3. Results
3.1. BCAP is an Abi-1-binding protein
Our previous study suggested that Abi-1 promotes c-Abl-
mediated phosphorylation of Mena, by interacting with both
c-Abl and the substrate [9]. To test the generality of this mech-
anism, we looked for c-Abl substrates, other than Mena, that
bind to Abi-1. Yeast two-hybrid screening of a human leuko-
cyte cDNA library was performed using Abi-1 as bait. We
anticipated that screening of a leukocyte cDNA library would
allow us to ﬁnd new Abi-1-binding proteins that are important
for the Abl-signaling pathway, because Abelson leukemia virus
preferentially transforms pre-B cells [11] and c-abl knockout
(/) mice exhibit lymphoid abnormalities [12,13]. Among
several clones obtained, one was found to encode a C-terminal
fragment aa 461–805 of BCAP. BCAP was identiﬁed as a mol-
ecule binding to phosphoinositide 3-kinase (PI3-K) [14], and
has been implicated in B cell development and humoral im-
mune responses [15,16].
We further analyzed the interaction between BCAP and Abi-
1 using the yeast two-hybrid system. Abi-1 contains an SH3
domain and a polyproline structure near the C terminus
(Fig. 1(a)). As shown in Fig. 1(b), Abi-1 (DPP) lacking aa
335–362 interacted with BCAP (461–805), whereas Abi-1
(DSH3) lacking aa 392–475 did not. These results suggest that
the SH3 domain, but not the polyproline structure, of Abi-1 is
critical for the interaction with BCAP.
Fig. 2. Analysis of BCAP phosphorylation by c-Abl kinase. 293T cells
were transfected with the expression plasmids indicated at the top.
GST–BCAP was pulled down as described in the legend of Fig. 1. The
precipitated proteins were analyzed by immunoblotting with anti-
phosphotyrosine and anti-GST antibodies. For estimation of the
amounts of expressed proteins, each cell lysate was separated and
immunoblotted with anti-Abl, anti-FLAG, and anti-GST antibodies
(WCL).
2988 M. Maruoka et al. / FEBS Letters 579 (2005) 2986–29903.2. Binding of BCAP to Abi-1 in mammalian cells
The interaction between BCAP and Abi-1 was conﬁrmed
using a mammalian cell system. Full-length BCAP cDNA
was ampliﬁed by PCR, and an expression plasmid for GST-
tagged BCAP was constructed, as described in Section 2.
GST or GST–BCAP was co-expressed with FLAG-tagged
Abi-1 in 293T cells, and then pulled down with glutathione
beads. As shown in Fig. 1(d), FLAG-Abi-1 co-precipitated
with GST–BCAP (lane 2), but not with GST (lane 1), indicat-
ing that exogenously expressed BCAP and Abi-1 interact with
each other in 293T cells.
We next investigated the Abi-1-binding region of BCAP.
Deletion mutants used in this study are schematically shown
in Fig. 1(c). Each was expressed as a GST-fusion protein in
293T cells with FLAG-Abi-1, and pull-down assays were per-
formed (Fig. 1(d)). As expected, FLAG-Abi-1 co-precipitated
with GST–BCAP (461–805) (lane 3), which contains the region
corresponding to the sequence encoded by the positive clone in
yeast two-hybrid screening. This fragment contains two polypr-
oline structure and one coiled-coil region (Fig. 1(c)). The fact
that the amount of FLAG-Abi-1 co-precipitating with GST–
BCAP (461–805) was larger than that with GST–BCAP sug-
gests that the N-terminal region may negatively regulate the
interaction between Abi-1 and BCAP. Deletion of the ﬁrst
polyproline structure had no eﬀect on the interaction (Fig.
1(d); compare lane 4 with lane 3). Notably, FLAG-Abi-1 was
pulled down with GST–BCAP (672–805), which possesses only
the C-terminal polyproline structure, albeit less eﬃciently than
with the mutant containing both the coiled-coil region and the
C-terminal polyproline structure (GST–BCAP (602–805)).
These results indicate that the C-terminal polyproline structure
is important for binding to Abi-1. Indeed, FLAG-Abi-1 was
not pulled down with GST–BCAP (1–759), a mutant lacking
only the C-terminal polyproline structure (Fig. 1(d), lane 6).
The C-terminal polyproline structure of BCAP is therefore crit-
ical for the interaction with Abi-1, and the coiled-coil region of
BCAP may contribute somewhat to the interaction.
3.3. Abi-1 promotes c-Abl-mediated phosphorylation of BCAP
Next, we examined whether or not Abi-1 aﬀects the phos-
phorylation of BCAP by c-Abl (Fig. 2). 293T cells were
cotransfected with the expression plasmids for c-Abl, FLAG-
Abi-1, and GST–BCAP. GST–BCAP was pulled down from
the cell lysates and its phosphorylation state was investigated
by Western blotting with anti-phosphotyrosine antibody. The
degree of phosphorylation of GST–BCAP was low when
GST–BCAP was co-expressed with c-Abl alone (Fig. 2, lane
3), but a marked increase was observed when GST–BCAP
was co-expressed with both FLAG-Abi-1 and c-Abl (lane 4).
Reprobing of the ﬁlter used to detect the phosphorylation state
of GST–BCAP with anti-GST antibody showed that compara-
ble levels of GST–BCAP existed in all samples. These results
demonstrate that Abi-1 promotes c-Abl-mediated phosphory-
lation of BCAP.
3.4. Tyosines 513, 553, 570, 594, and 694 are the
phosphorylation sites of BCAP
BCAP (461–805) contains ﬁve tyrosine residues (aa 513, 553,
570, 594, and 694), which are conserved in other species includ-
ing chicken, mouse and rat. To examine if these tyrosines are
phosphorylated by c-Abl kinase, we made BCAP mutants in
which either four (Y513, Y553, Y570, Y594, and Y694) orall (CT5F) of these tyrosines were replaced by phenylalanines
(Fig. 3(a)). Plasmids encoding c-Abl, FLAG-tagged Abi-1, and
the GST–BCAP mutants were cotransfected into 293T cells.
The GST–BCAP mutants were pulled down and their phos-
phorylation status was assessed by Western blotting with
anti-phosphotyrosine antibody.
As shown in Fig. 3(b), wild-type BCAP and mutants retain-
ing one tyrosine residue were phosphorylated to varying de-
grees, whereas the CT5F mutant was not phosphorylated
(lane 7). These results indicate that all ﬁve tyrosine residues
in the C-terminal region of BCAP are phosphorylated by c-
Abl kinase.
3.5. Phosphorylation of BCAP by v-Abl
Oncogenic forms of Abl, namely v-Abl and Bcr-Abl, possess
increased and unregulated kinase activities [3,17]. We next
examined the eﬀect of Abi-1 on v-Abl-mediated phosphoryla-
tion of BCAP. 293T cells were cotransfected with the
expression plasmids for v-Abl, FLAG-Abi-1 and either
GST–BCAP or GST–BCAP CT5F. GST–BCAP and CT5F
were pulled down and their phosphorylation status was inves-
tigated. As shown in Fig. 4, although v-Abl phosphorylated
GST–BCAP in the absence of Abi-1, the levels of GST–BCAP
phosphorylation were higher in its presence. Phosphorylation
of GST–BCAP CT5F was barely detectable, regardless of
whether or not Abi-1 was present. Abi-1 thus promotes phos-
phorylation of BCAP by v-Abl as well as by c-Abl.4. Discussion
We showed previously that Abi-1 promotes c-Abl-mediated
phosphorylation of Mena, via interactions with both c-Abl
and Mena [9]. In the present study, we searched for other c-
Abl substrates whose phosphorylation is promoted by Abi-1.
BCAP was identiﬁed as an Abi-1-binding protein, and Abi-1
Fig. 3. Phosphorylation sites of BCAP. (a) Schematic representation
of the mutants of BCAP. X denotes the positions of mutated tyrosine
residues. (b) 293T cells were cotransfected with the expression plasmids
for c-Abl, FLAG-Abi-1, and either GST–BCAP (wild type) or one of
its mutants (Y513, Y553, Y570, Y594, Y2694, or CT5F), as indicated
at the top. GST–BCAP or its mutants were pulled down from the cell
lysates as described in the legend to Fig. 1, and then the precipitated
proteins were then analyzed by immunoblotting with anti-phosphoty-
rosine and anti-GST antibodies (GST pull-down). Each cell lysate was
subjected to immunoblotting with anti-Abl, anti-GST, and anti-FLAG
antibodies (WCL).
Fig. 4. Analysis of BCAP phosphorylation by v-Abl kinase. (a) 293T
cells were transfected with the expression plasmids indicated at the top.
GST–BCAP or the GST–BCAP CT5F mutant was pulled down from
the cell lysates, and the precipitated proteins were analyzed by
immunoblotting with anti-phosphotyrosine and anti-GST antibodies
(GST pull-down). Each cell lysate was subjected to immunoblotting
with anti-Abl, anti-FLAG, and anti-GST antibodies (WCL).
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taken together suggest that Abi-1 is a general coordinator of
kinase–substrate interactions.The interaction between Abi-1 and BCAP occurred both in
yeast (two-hybrid analysis) and in mammalian cells (GST pull-
down experiments). The results showed that the SH3 domain,
but not the polyproline structure, of Abi-1 is critical for the
interaction with BCAP. Conversely, the polyproline structure,
rather than the SH3 domain is critical for the interaction with
Mena. Therefore, the binding surfaces of Abi-1 for these two
substrates must be diﬀerent. The SH3 domain of Abi-1 has
also been reported to interact with c-Abl [10], and Fan et al.
[18] showed recently that Abi-1 forms oligomers for its func-
tion. Oligomerization of Abi-1 might generate multiple bind-
ing sites and permit complex interactions; for example,
diﬀerent Abi-1 molecules within an oligomer could bind to c-
Abl kinase and substrate.
The molecular mechanism by which Abi-1 activates c-Abl is
not known. Recently, Woodring et al. [19] showed that Crk
adaptor protein overcomes the actin-mediated inhibition of
c-Abl. Although the precise mechanism of adaptor-regulated
activation of c-Abl remains unclear, kinase activation and
the adaptor–substrate interaction both seem to be important.
As shown in Fig. 4, Abi-1 also promotes v-Abl-mediated phos-
phorylation of BCAP. Abi-1 may be necessary for both c-Abl
and v-Abl to recognize BCAP as a substrate. Alternatively,
Abi-1 may positively regulate BCAP as a substrate for Abl ki-
nases. Interactions between Abi-1 and BCAP may result in
structural changes to BCAP, leading in turn to eﬀective phos-
phorylation by Abl kinases.
Analysis of bcap(/) mice showed that BCAP plays an
important role in B cell development and function [16]. c-
abl(/) mice exhibit abnormalities in B cell progenitor cells
[12,13]. Abelson leukemia virus, possessing the v-abl onco-
gene, transforms pre-B cells [11,12]. These observations sug-
gest a functional link between BCAP and c-Abl in B cells.
Previous studies revealed that the tyrosine residues in the
N-terminal region of BCAP are phosphorylated by both
Syk and Btk kinases [14]. Mutational analysis also suggested
that other tyrosine residues of BCAP were phosphorylated
in B cells that were stimulated by the receptors [14,20]. It
is possible that the C-terminal tyrosine residues of BCAP
are phosphorylated in B cells by c-Abl that has been acti-
vated by stimuli such as CD19 [21] or integrin [22]. In this
way, BCAP and Abl kinases may coordinate to regulate B
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